TAXUS EXPRESS2 PACLITAXEL-ELUTING CORONARY STENT SYSTEM
Report
- Report Number
- 2134265-2011-02452
- Event Type
- Injury
- Date Received
- June 28, 2011
- Date of Event
- March 31, 2011
- Report Date
- May 31, 2011
- Manufacturer
- BOSTON SCIENTIFIC - MAPLE GROVE
- Product Code
- NIQ
- PMA / PMN Number
- P030025
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- FL, US
- Reporter Occupation
- PATIENT
Narratives
DEVICE IS A COMBINATION PRODUCT DEVICE EVALUATED BY MANUFACTURER - IT IS INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVALUATION; THEREFORE A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. A REVIEW OF THE BATCH HISTORY, HISTORICAL TRENDING, AND SIMILAR COMPLAINT TRENDING REVIEW FOR THE PRODUCT FAMILY WILL BE CONDUCTED. IF THERE IS ANY FURTHER RELEVANT INFORMATION FROM THAT REVIEW, A SUPPLEMENTAL MEDWATCH WILL BE FILED. (B)(4).
IT WAS REPORTED THAT POST A STENTING TREATMENT PROCEDURE, A STENT OCCLUSION OCCURRED. IN (B)(6) 2005, THE LESION BEING TREATED WAS LOCATED IN THE LEFT ANTERIOR DESCENDING (LAD) ARTERY. THE PHYSICIAN IMPLANTED A 2.75X20MM TAXUS EXPRESS 2 STENT. IN MARCH 2011, THE PATIENT EXPERIENCED A HEART ATTACK. ACCESS WAS OBTAINED IN THE RIGHT FEMORAL ARTERY. THE PREVIOUSLY PLACED TAXUS EXPRESS 2 STENT WAS FOUND TO CONTAIN A CHRONIC TOTAL OCCLUSION. THE ATTEMPTS MADE TO PLACE NON-BSC GUIDE WIRES IN THE LAD WERE UNSUCCESSFUL. THE PHYSICIAN IMPLANTED A 3.0X28MM PROMUS STENT IN THE 99% STENOSED MID RIGHT CORONARY ARTERY (RCA) AND A 3.0X12MM PROMUS STENT WAS IMPLANTED IN THE 80% STENOSED MID POSTEROLATERAL ARTERY (PLA) WITH EXCELLENT RESULTS. RESIDUAL STENOSIS WAS 0% WITH A TIMI 3 FLOW. MEDICATIONS GIVEN INCLUDED: INTEGRILIN, PLAVIX, AND ASPIRIN. THE PATIENT WILL CONTINUE "AGGRESSIVE MEDICATION". HOWEVER, THE MEDICATION IS HURTING THE PATIENT'S ARMS, BRUISES IN THE BLOOD VESSELS UNDERNEATH THE BRACHIAL, AND ITCHING.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | TAXUS EXPRESS2 PACLITAXEL-ELUTING CORONARY STENT SYSTEM | CORONARY DRUG-ELUTING STENT | NIQ | BOSTON SCIENTIFIC - MAPLE GROVE | H7493897020270 | 7138200 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 64 YR | Required Intervention |